Amphastar Pharmaceuticals, Inc. — Director's Dealing 2019

Sep 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2019-09-11

Reporting Person: Zhang Jack Y. (Director, CEO & Chief Scientific Officer, 10% Owner)
Reporting Person: Luo Mary Z. (Director, COO,Chief Scientist & Chairman, 10% Owner)
Reporting Person: Applied Physics & Chemistry Laboratories, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-11	Common Stock	S	300000	$20.82	Disposed	7027679	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2147316	Direct
Common Stock	1399022	Indirect
Common Stock	5000	Indirect
Common Stock	200000	Indirect

Footnotes

F1: The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust (the "BLZ Trust") are the sole owners.

F2: The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.

F3: The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.

F4: The shares are held of record by the BLZ Trust. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.